In this webinar, we will hear from Phenomenex’s Senior Research Scientist, Shilin Cheung as we delve into chromatography’s vital role in ensuring quality and safety of Adeno-Associated Viruses (AAVs) in drug development. We’ll explore the latest modern chromatographic techniques designed to support AAV quantification and characterization.
Critical quality attributes (CQAs) play a pivotal role in every stage of the drug development process. This session will guide you through the nuances of CQAs, providing a comprehensive understanding of their significance and impact. You'll gain valuable insights into how to navigate common challenges posed by CQAs at various development stages, ensuring that your AAV-based therapies meet the highest industry standards.
As we progress, we'll discuss the importance of selecting fit-for-purpose chemistries and method conditions, specifically tailored to address common CQA tests. These insights are instrumental in ensuring that your analytical methods are robust, efficient, and precise.